-
Prior Infection with Torque Teno Virus Mitigates Influenza Pathology in Mice -
Effect of Acid-Stabilizing Hemagglutinin Mutations on Immunogenicity and Heterologous Protection by H1N1 Influenza Virus mRNA-LNP Vaccines -
Dynamic Changes in Host Immune Response During Crimean–Congo Hemorrhagic Fever and Severe Fever with Thrombocytopenia Syndrome in Mice -
Mapping Determinants of Hepatitis C Virus E1/E2 Transmembrane Interactions Using Intergenotypic Chimeras -
RNA Folding Energy of Long-Range Genomic Interactions Regulates Discontinuous Transcription in SARS-CoV-2
Journal Description
Viruses
Viruses
is a peer-reviewed, open access journal of virology, published monthly online by MDPI. The Spanish Society for Virology (SEV), Canadian Society for Virology (CSV), Italian Society for Virology (SIV-ISV), Australasian Virology Society (AVS), Brazilian Society for Virology (BSV) and Global Virus Network (GVN) are affiliated with Viruses and their members receive a discount on the article processing charges.
- Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
- High Visibility: indexed within Scopus, SCIE (Web of Science), PubMed, MEDLINE, PMC, Embase, PubAg, and other databases.
- Journal Rank: JCR - Q2 (Virology) / CiteScore - Q1 (Infectious Diseases)
- Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 15.5 days after submission; acceptance to publication is undertaken in 2.9 days (median values for papers published in this journal in the first half of 2026).
- Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.
- Journal Cluster of Microbiology: Acta Microbiologica Hellenica, Applied Microbiology, Bacteria, Journal of Fungi, Microorganisms, Microbiology Research, Pathogens, Viruses, Fermentation and Germs.
Impact Factor:
3.8 (2025);
5-Year Impact Factor:
3.8 (2025)
Latest Articles
Subzero Control of Human Norovirus and Indicator Microorganisms on Frozen Foods Using an Antifreeze–Peracetic Acid Formulation
Viruses 2026, 18(8), 846; https://doi.org/10.3390/v18080846 (registering DOI) - 1 Aug 2026
Abstract
Human norovirus (HuNoV) is one of the most important foodborne viruses and poses a significant risk in frozen foods along the cold chain. Traditional disinfectants exhibit reduced efficacy in frozen matrices and often fail to meet the requirements for food applications. This study
[...] Read more.
Human norovirus (HuNoV) is one of the most important foodborne viruses and poses a significant risk in frozen foods along the cold chain. Traditional disinfectants exhibit reduced efficacy in frozen matrices and often fail to meet the requirements for food applications. This study optimized and evaluated a novel antifreeze–peracetic acid formulation (Af-PAA) for application on frozen foods, achieving disinfection performance at −40 °C. The formulation was optimized using four indicator microorganisms, with effective Af-PAA concentrations of 200 mg/L for Escherichia coli, 200 mg/L for Staphylococcus aureus, 500 mg/L for Candida albicans, and 2000 mg/L for Aspergillus niger. HuNoV GII.4[P31] propagated in zebrafish was inoculated onto frozen food samples. The frozen blueberries (500 mg/L), carrots (500 mg/L), chicken breast (2000 mg/L), and Arctic shrimp (2000 mg/L) were then subjected to Af-PAA treatment at −40 °C for 60 min with 60 s vortex mixing. RNase-RT-qPCR analysis showed a 3.0–3.1 log10 reduction in RNase-resistant HuNoV RNA signals across all tested food under the corresponding treatment concentrations. No visual changes were observed in treated foods. This study demonstrated that Af-PAA met tested food disinfectant requirements and effectively inactivated indicator microorganisms. HuNoV signals were also markedly reduced on the tested foods. These findings support its application for microbial risk control in cold-chain foods.
Full article
(This article belongs to the Special Issue Enteric Viruses in Environment and Humans: Identification, Surveillance and Control)
►
Show Figures
Open AccessArticle
Clinical Profile, of Adults Hospitalised with Mpox and Exploratory Associations with HIV Infection and Selected Comorbidities in South Kivu, Democratic Republic of the Congo: A Multicentre Retrospective Study
by
Christian Tshongo Muhindo, Isaac Barhishindi, Arsène Daniel Nyalundja, Marina Saleeb, Mudarshiru Bbuye, Bruce Kirenga, Misaki Wayengera, Espoir Bwenge Malembaka, David Lupande Mwenebitu, Samuel Makali, Susanne Krasemann, Mannix Masimango, Samir Kumar-Singh, Robert Colebunders, Patrick D. M. C. Katoto and Joseph Nelson Siewe Fodjo
Viruses 2026, 18(8), 845; https://doi.org/10.3390/v18080845 (registering DOI) - 1 Aug 2026
Abstract
Mpox remains endemic in the Democratic Republic of the Congo (DRC), where co-endemic infections and non-communicable comorbidities may influence disease severity and clinical outcomes. However, data on associated factors of adverse outcomes among hospitalised adults with mpox in African settings remain limited. This
[...] Read more.
Mpox remains endemic in the Democratic Republic of the Congo (DRC), where co-endemic infections and non-communicable comorbidities may influence disease severity and clinical outcomes. However, data on associated factors of adverse outcomes among hospitalised adults with mpox in African settings remain limited. This study aimed to describe the clinical profile of adults hospitalised with mpox in South Kivu Province, eastern DRC, and to explore associations between selected comorbid conditions, including HIV infection, malaria, and hyperglycaemia, and mpox disease severity, mortality, and hospitalisation duration. We conducted a multicentre retrospective observational study among adults admitted to five mpox treatment centres in South Kivu Province, DRC, between January 2024 and December 2025. Demographic, clinical, and laboratory data were extracted from routine hospital registers. Mpox disease severity (available only for a subset of participants) was classified according to WHO criteria. Participants included adults with suspected, probable or laboratory-confirmed mpox according to WHO case definitions in use during the study period. In addition to mpox disease severity, outcomes of interest included in-hospital mortality and duration of hospitalisation. Multivariable regression models were used to explore associations between selected comorbidities and clinical outcomes after adjustment for age and sex. Among 652 hospitalised adults included in the analysis, the median age was 26 years (IQR 21.0–35.0), and 383/652 (58.7%) were female. Among patients with recorded severity data (n = 104), moderate or severe mpox was documented in 88/104 (84.6%) patients. Overall mortality was 14/645 (2.2%). HIV infection was identified in 5 of the 71 participants tested (7.0%). Among participants with available test results, HIV infection appeared to be associated with higher mpox severity and mortality. Increasing age, but not HIV infection, malaria, or glycaemic status, was associated with longer hospitalisation. Because laboratory investigations were performed in only a subset of participants and missing data were substantial, these findings should be interpreted cautiously and considered exploratory. Prospective studies incorporating systematic laboratory testing and standardised clinical data collection are needed to better define factors associated with severe mpox in endemic African settings.
Full article
(This article belongs to the Special Issue Mpox (Monkeypox): From Neglected Tropical Disease to Emerging Global Pathogen)
►▼
Show Figures

Figure 1
Open AccessCommentary
Sustaining Mpox Surveillance, Research, and Care Integration in a Post-PHEIC, Resource-Constrained World
by
Patrick D. M. C. Katoto and Liliane Nsuli Byamungu
Viruses 2026, 18(8), 844; https://doi.org/10.3390/v18080844 (registering DOI) - 1 Aug 2026
Abstract
In August 2024, the Africa Centres for Disease Control and Prevention (Africa CDC) declared mpox a Public Health Emergency of Continental Security (PHECS), and the World Health Organization (WHO) followed with a second Public Health Emergency of International Concern (PHEIC), in response to
[...] Read more.
In August 2024, the Africa Centres for Disease Control and Prevention (Africa CDC) declared mpox a Public Health Emergency of Continental Security (PHECS), and the World Health Organization (WHO) followed with a second Public Health Emergency of International Concern (PHEIC), in response to the rapid expansion of clade Ib monkeypox virus (MPXV) across eastern Democratic Republic of the Congo (DRC) and neighboring countries. Both declarations have since been lifted (September 2025 and January 2026), yet clade Ib transmission and severe outcomes in pregnant women and children persist. We argue that closing these emergency mechanisms marks not the end of the epidemic but the start of a harder phase: sustaining surveillance, care, and research amid shrinking donor support, including the dissolution of the United States Agency for International Development (USAID). We contend that integrating mpox into existing HIV, sexually transmitted infection (STI), and reproductive health platforms is the most realistic route to durable routine care, while pregnancy, paediatric disease, severe cases, and zoonotic spillover still need dedicated pathways. Sustainable management ultimately depends on domesticated financing, stronger institutions, genuine community engagement, and action on the ecological drivers of spillover.
Full article
(This article belongs to the Special Issue Mpox (Monkeypox): From Neglected Tropical Disease to Emerging Global Pathogen)
Open AccessArticle
FluEvoFormer: A Structure-Guided Generative Foundation Model for Prospective Influenza Antigenic Evolution and Vaccine Strain Selection
by
Pankaj Agarwal, Sumendra Yogarayan and Md. Shohel Sayeed
Viruses 2026, 18(8), 843; https://doi.org/10.3390/v18080843 (registering DOI) - 1 Aug 2026
Abstract
Seasonal influenza vaccine strain selection remains challenging because circulating viruses may drift after vaccine recommendations are made. This study presents FluEvoFormer, a structure-guided generative foundation model for prospective influenza antigenic evolution forecasting and vaccine strain ranking. The framework jointly encodes hemagglutinin and neuraminidase
[...] Read more.
Seasonal influenza vaccine strain selection remains challenging because circulating viruses may drift after vaccine recommendations are made. This study presents FluEvoFormer, a structure-guided generative foundation model for prospective influenza antigenic evolution forecasting and vaccine strain ranking. The framework jointly encodes hemagglutinin and neuraminidase sequences and incorporates residue-contact graphs. Separate prediction heads estimate future viral dominance and the vaccine–virus antigenic match. Controlled future-like variant stress testing, uncertainty adjustments, and clade balancing are then used to rank vaccine candidates. A rolling retrospective evaluation was performed for target seasons involving the influenza A(H1N1)pdm09 virus and influenza A(H3N2) virus. The evaluation used cutoff-restricted sequence records, hemagglutination inhibition data, vaccine-composition records, protein-structure resources, and vaccine-effectiveness indicators. The historical training corpus for the influenza A(H1N1) virus also contained pre-2009 seasonal records. FluEvoFormer achieved the lowest held-out antigenicity prediction error, with mean absolute error (MAE) values of 0.389 for the combined historical influenza A(H1N1) virus corpus and 0.456 for the influenza A(H3N2) virus corpus. It also improved the future dominance prediction, with Kullback–Leibler (KL) divergence values of 0.255 and 0.289, respectively. The model selected candidates with higher empirical normalized coverage scores in seven out of 10 influenza A(H1N1)pdm09 virus seasons and nine out of 10 influenza A(H3N2) virus seasons. The predicted coverage score showed a strong positive correlation with external vaccine-effectiveness estimates. These findings support FluEvoFormer as a computational decision-support framework for prioritizing influenza vaccine candidates before downstream laboratory and public health evaluations.
Full article
(This article belongs to the Section Viral Immunology, Vaccines, and Antivirals)
Open AccessArticle
Enterococcus Phage Abitsa: Biological Characterization, Antibiofilm Activity and Evolutionary Insights into the Genus Efquatrovirus
by
Konstantin S. Troshin, Lydia I. Ilyenko, Andrei V. Chaplin, Anastasiya A. Khritova, George A. Skvortsov, Anna A. Vasilyeva, Olga Y. Guseva, Igor S. Kopetskiy, Dmitriy A. Shagin, Lyudmila I. Kafarskaia, Boris A. Efimov, Artem A. Malkov, Maxim A. Sokolovskiy and Peter V. Evseev
Viruses 2026, 18(8), 842; https://doi.org/10.3390/v18080842 (registering DOI) - 1 Aug 2026
Abstract
Enterococcus faecalis is an important opportunistic pathogen associated with persistent oral infections, biofilm formation, and antimicrobial tolerance, which makes phages targeting this species of both therapeutic and evolutionary interest. Here, we describe the isolation and characterization of Abitsa, a novel lytic Enterococcus phage
[...] Read more.
Enterococcus faecalis is an important opportunistic pathogen associated with persistent oral infections, biofilm formation, and antimicrobial tolerance, which makes phages targeting this species of both therapeutic and evolutionary interest. Here, we describe the isolation and characterization of Abitsa, a novel lytic Enterococcus phage representing a new species within the genus Efquatrovirus. Abitsa formed small plaques and displayed siphovirus-like morphology. It showed an optimal multiplicity of infection of 0.01, a short latent period of 10 min and a burst size of 28 ± 5 virions per infected cell. The phage efficiently suppressed planktonic growth of E. faecalis over a broad multiplicity of infection (MOI) range and significantly disrupted pre-formed biofilms, with the strongest effect observed at MOI 0.1, resulting in an 82.14% reduction in biofilm biomass. Abitsa remained stable at pH 4–8, at 5–50 °C for 1 h, and in up to 75% chloroform, but exhibited a narrow host range, lysing only one additional clinical E. faecalis isolate among 34 tested enterococcal isolates. Genome analysis showed that Abitsa has a 41,581-bp linear genome lacking lysogeny-associated genes and represents a novel Efquatrovirus species. Comparative structural and phylogenetic analyses additionally supported mosaic evolution and extensive domain shuffling in receptor-binding and lysis-related proteins of Efquatrovirus-like phages. Together, these results identify Abitsa as a biologically unusual and evolutionarily informative lytic phage with antibiofilm activity.
Full article
(This article belongs to the Section Bacterial Viruses)
►▼
Show Figures

Figure 1
Open AccessArticle
Dual Antiviral Functions of Antibodies Targeting African Swine Fever Virus p17 Protein: Viral Inhibition and ADCC Induction
by
Shengmei Chen, Chunhao Jiang, Zhanhao Lu, Jing Lan, Qiang Fu, Yuan Sun, Tao Wang and Hua-Ji Qiu
Viruses 2026, 18(8), 841; https://doi.org/10.3390/v18080841 (registering DOI) - 1 Aug 2026
Abstract
African swine fever virus (ASFV) causes African swine fever (ASF), a highly lethal disease in pigs. Vietnam has approved two ASF live-attenuated vaccines (LAVs), but their efficacy and safety remain controversial, and no reliable, highly effective commercial ASF vaccine is available yet. Humoral
[...] Read more.
African swine fever virus (ASFV) causes African swine fever (ASF), a highly lethal disease in pigs. Vietnam has approved two ASF live-attenuated vaccines (LAVs), but their efficacy and safety remain controversial, and no reliable, highly effective commercial ASF vaccine is available yet. Humoral immunity plays an important role in protection against ASFV infection. However, there is still controversy regarding whether ASFV infection can induce antibodies with neutralizing activity. Antibody-dependent cellular cytotoxicity (ADCC), as an antibody-mediated protective mechanism, offers a novel perspective for screening protective ASFV antigens. This study evaluated five structural proteins (pCP312R, pA104R, pA151R, p17, and pF317L) as subunit vaccine candidates based on their ability to induce antibodies that inhibit viral replication and mediate ADCC. The recombinant proteins were expressed in Escherichia coli, purified, and used to immunize pigs. Immune sera collected two weeks after the third immunization were tested for their ability to inhibit ASFV replication in porcine alveolar macrophages (PAMs) using rASFV-Gluc/EGFP. ADCC activity was assessed using a stable HEK293T-p17 cell line as target cells and porcine peripheral blood mononuclear cells (PBMCs) as effectors, with cytotoxicity measured by lactate dehydrogenase release. All five recombinant proteins were successfully expressed and purified. Immunization with pCP312R, pA104R, p17, and pF317L induced the production of specific antibodies in pigs, but only anti-p17 antibodies significantly inhibited ASFV replication in PAMs. The p17 is highly conserved across different ASFV genotypes and is predicted to contain a transmembrane domain. Anti-p17 antibodies effectively mediated PBMCs to specifically kill target cells, demonstrating significant ADCC activity. Moreover, the HEK293T-p17 cell line was specifically recognized by anti-ASFV sera. These findings indicate that p17 is a dual-functional antigen capable of eliciting antibodies that both inhibit viral replication and mediate ADCC in vitro. Furthermore, we have developed an in vitro platform for screening protective ASFV antibodies based on viral inhibition and ADCC, providing candidate targets for the development of next-generation ASF subunit vaccines.
Full article
(This article belongs to the Collection African Swine Fever Virus (ASFV))
►▼
Show Figures

Figure 1
Open AccessArticle
Long-Term Epidemiological Trends and Risk Factors of Crimean–Congo Hemorrhagic Fever in Kazakhstan: An Integrated Epidemiological and Entomological Analysis
by
Gulzhan N. Abuova, Yerkin B. Bukharbayev, Farida A. Berdaliyeva, Natalia Yu. Pshenichnaya and Bekzhan Ye. Bektan
Viruses 2026, 18(8), 840; https://doi.org/10.3390/v18080840 - 31 Jul 2026
Abstract
Crimean–Congo hemorrhagic fever (CCHF) remains a major tick-borne zoonotic infection and a persistent public health challenge in Central Asia. Kazakhstan is among the endemic countries, where natural foci of CCHF are concentrated predominantly in the southern regions. This study evaluated the long-term epidemiological
[...] Read more.
Crimean–Congo hemorrhagic fever (CCHF) remains a major tick-borne zoonotic infection and a persistent public health challenge in Central Asia. Kazakhstan is among the endemic countries, where natural foci of CCHF are concentrated predominantly in the southern regions. This study evaluated the long-term epidemiological trends, regional distribution, seasonality, and risk factors associated with CCHF in Kazakhstan. A retrospective analysis of national surveillance data from 1980 to 2023 was conducted, complemented by detailed epidemiological and entomological investigations in the Turkestan region and the city of Shymkent during 2011–2023. Laboratory-confirmed cases, tick bite-related healthcare visits, entomological surveillance data, demographic characteristics, and epidemiological risk factors were analyzed. The results demonstrated cyclic fluctuations in CCHF incidence, with epidemic peaks occurring every 4–6 years and pronounced spring–summer seasonality, with the highest incidence observed in June and July. Long-term average annual incidence in endemic southern regions exceeded the national average by 2.67-fold. A total of 50,671 tick bite-related healthcare visits were registered during 2011–2023, while their incidence declined over time. Analysis of 94 laboratory-confirmed cases identified adults aged 18–40 years as the most affected group. Tick bites and livestock-related activities were the principal risk factors. These findings support the strengthening of integrated surveillance, vector control, laboratory diagnostics, and One Health-based prevention strategies in endemic regions.
Full article
(This article belongs to the Special Issue Crimean-Congo Hemorrhagic Fever Virus (CCHFV))
►▼
Show Figures

Figure 1
Open AccessArticle
Assessment of Population Immunity Against Peste des Petits Ruminants in Goats and Sheep in India After the Second Annual Mass Vaccination Implemented Under the National PPR Eradication Programme
by
Kirubakaran Vinod Kumar, Rakshit Ojha, Ramachandra Deshpande, Shweta Priya, Akshatha Lokanath Goudar, Umathul Ayesha, Ponnidurai Malini, Prajakta Prashant Bokade, Anand Asha, Gangarajareddy Deekshitha, Annett Helcita Dsouza, Archana Pal, Akula Dakshitha, Shakuntala Krishnaiah Harshitha, Mahadevappa Swathi, Roopa Anandamurthy Hemanth, Lakshmipathy Archudhan, Shanmugam ChandraSekar, Kuralayanapalya Puttahonnappa Suresh, GurrappaNaidu Govindaraj, Nayakvadi Shivasharanappa, Paramanandham Krishnamoorthy, Sujit Nayak, Njeumi Felix, Baldev Raj Gulati, Satya Parida and Vinayagamurthy Balamuruganadd
Show full author list
remove
Hide full author list
Viruses 2026, 18(8), 839; https://doi.org/10.3390/v18080839 - 30 Jul 2026
Abstract
This study evaluated population immunity against peste des petits ruminants (PPR) in sheep and goats in India following the second annual round of mass vaccination conducted under the National PPR Eradication Programme (PPR EP), launched in 2023 in accordance with the national strategic
[...] Read more.
This study evaluated population immunity against peste des petits ruminants (PPR) in sheep and goats in India following the second annual round of mass vaccination conducted under the National PPR Eradication Programme (PPR EP), launched in 2023 in accordance with the national strategic plan. A cross-sectional post-vaccination evaluation (PVE) was conducted during August 2024 and April 2026 to assess the herd or population immunity under field conditions, in line with the WOAH and FAO Global Control and Eradication Strategy (GCES) of the PPR Global Eradication Programme (PPR GEP) 2030. A total of 52,133 serum samples were collected within 90 days post vaccination from sheep and goats across three age groups, 6–12 months (n = 18,002), 1–2 years (n = 17,316), and >2 years (n = 16,842), representing 1666 epidemiological units across multiple taluks and districts in 20 Indian states and Union Territories. Serum samples were tested for antibodies against PPR virus using in-house IVRI developed hemagglutinin (H) protein monoclonal antibody based competitive ELISA. The study revealed an overall population immunity of 72%, with age-wise PPRV antibody prevalence of 70.8%, 71.8%, and 72.6% in the 6–12-month, 1–2-year, and >2-year age groups, respectively. Statistical analysis showed significant associations (p < 0.005) between PPRV seropositivity and host factors, including species. Population immunity increased markedly from 41% (pre-vaccination sero-prevalence) in 2023 to nearly 72% by 2025-26 following two consecutive rounds of annual vaccination, accompanied by a substantial reduction in confirmed outbreaks from 57 during 2023 to 20 in 2025 in these 20 states/Union Territories. Notably, about 14.5% of epidemiological units remained below 30% seroprevalence, indicating targeted gaps requiring intensified vaccination. Overall animal vaccination coverage exceeded 95% among small ruminants aged above four months, approaching the population immunity threshold of 70 to 80%. These findings highlight the critical role of sustained successive mass vaccination campaigns in achieving and maintaining protective herd/population immunity, thereby supporting national and global PPR eradication goals.
Full article
(This article belongs to the Section Animal Viruses)
►▼
Show Figures

Figure 1
Open AccessArticle
Assessment of Quantitative Genetic Distances Supports the Separation of H17N10 and H18N11 Subtypes of Influenza A Virus into a Distinct Species
by
Ilya A. Volkhin, Mariia A. Dashian, Alexander N. Lukashev, German A. Shipulin and Andrei A. Deviatkin
Viruses 2026, 18(8), 838; https://doi.org/10.3390/v18080838 - 30 Jul 2026
Abstract
The taxonomic status of the H17N10 and H18N11 influenza A viruses isolated from bats remains unclear due to the absence of quantitative classification criteria at this taxonomic level. A total of 3328 representative IAV genomes, encompassing all eight protein-coding segments, were analysed. Various
[...] Read more.
The taxonomic status of the H17N10 and H18N11 influenza A viruses isolated from bats remains unclear due to the absence of quantitative classification criteria at this taxonomic level. A total of 3328 representative IAV genomes, encompassing all eight protein-coding segments, were analysed. Various genetic distance-based metrics were assessed at the pairwise level, including intra- and intergroup nucleotide distances, dN/dS ratios, and transition/transversion ratios, to facilitate the differentiation of the Alphainfluenzavirus genus into distinct taxa. Pairwise distances for seven of the eight segments (PB2, PB1, PA, NP, M, NA, NS) consistently differentiated the H17–H18 group from H1–H16. Across segments, intergroup nucleotide divergence was consistently above a lower bound of ~25%, with segment-specific values extending to higher levels (up to ~40% in PB2 and PA), while intragroup divergence remained substantially lower. The HA segment did not conform to this pattern, which is consistent with the hypothesis of ancient reassortment. The distribution of pairwise dN/dS values for the PB2, PB1, PA, and NP segments is evidently bimodal. Intergroup comparisons were consistently higher across all segments, whereas intragroup values remained lower. A similar lower boundary of approximately 0.12 was observed across segments, while the upper range of intergroup values varied by gene. Overall, the results support a consistent gene-specific separation pattern. Previously demonstrated absence of reassortment compatibility between bat viruses (H17–H18) and canonical influenza A (H1–H16) viruses indicates that these lineages have evolved independently over an extended period. These consistent genomic patterns provide support for the hypothesis that H17N10 and H18N11 viruses may represent a separate species within the genus Alphainfluenzavirus.
Full article
(This article belongs to the Special Issue Molecular Epidemiology, Evolution, and Transmission of Avian Influenza Viruses: 2nd Edition)
►▼
Show Figures

Figure 1
Open AccessCorrection
Correction: Mumo et al. Genetic and Antigenic Characterization of Bovine and Porcine Respiratory Coronaviruses Circulating in Western Europe, 2020–2023. Viruses 2026, 18, 705
by
Ruth M. Mumo, Anna Parys, Sieglinde Coppens, Nick Vereecke, Sebastiaan Theuns, Bart Pardon and Kristien Van Reeth
Viruses 2026, 18(8), 837; https://doi.org/10.3390/v18080837 - 30 Jul 2026
Abstract
Addition of Authors [...]
Full article
(This article belongs to the Section Coronaviruses)
Open AccessArticle
Using Lateral Flow Devices to Enhance Molecular Epidemiology and Evaluating the Rabies Surveillance System on Unguja Island, Zanzibar
by
Cayla Bosch, Ali Z. Moh’D, Ramadhan J. Ramadhan, Andre Coetzer, Ayla J. Malan, Louis H. Nel and Nicolette Wright
Viruses 2026, 18(8), 836; https://doi.org/10.3390/v18080836 - 29 Jul 2026
Abstract
Dog rabies remains a neglected tropical disease in many resource-limited endemic regions, including Unguja Island, Zanzibar. Classically, in such resource-limited settings, an underestimation of the impact of rabies, which directly correlates with insufficient diagnostic capabilities and surveillance efforts, leads to poor investment in
[...] Read more.
Dog rabies remains a neglected tropical disease in many resource-limited endemic regions, including Unguja Island, Zanzibar. Classically, in such resource-limited settings, an underestimation of the impact of rabies, which directly correlates with insufficient diagnostic capabilities and surveillance efforts, leads to poor investment in effective rabies control. This study combined molecular epidemiology with retrospective analyses of surveillance data from 2016 to 2024 to better understand the transmission dynamics and assess the effectiveness and reliability of the rabies surveillance system on Unguja Island. Towards this goal, rabies RNA was extracted from used lateral flow devices for further molecular phylogenetic analyses of the partial nucleoprotein gene. From this analysis, we were able to conclude that the rabies lyssaviruses presently circulating on Unguja Island represent a distinct endemic cycle in comparison to rabies viruses from elsewhere in Tanzania. In addition, space–time analysis and the evaluation of testing rates identified high-risk rabies areas with particularly inadequate surveillance. These findings allow better understandings of the disease’s impact, which will support improved surveillance and the implementation of targeted control strategies, and will pave the way for, hopefully, the elimination of dog rabies in the longer run.
Full article
(This article belongs to the Special Issue Early Diagnosis and Surveillance of Transboundary and Emerging Viral Diseases of Animals, 2nd Edition)
►▼
Show Figures

Figure 1
Open AccessRetraction
RETRACTED: Iftikhar et al. Endogenous Retroviruses as Regulators of Innate Immune Signaling and Inflammation. Viruses 2026, 18, 289
by
Muhammad Iftikhar, Xinyan Wang, Qiangzhou Wang, Jiaxing Wang, Lihong Gu and Shihao Chen
Viruses 2026, 18(8), 835; https://doi.org/10.3390/v18080835 - 29 Jul 2026
Abstract
Viruses retracts the review article titled “Endogenous Retroviruses as Regulators of Innate Immune Signaling and Inflammation” [...]
Full article
(This article belongs to the Section General Virology)
Open AccessArticle
Zika Virus NS3 Drives the Assembly of a Replication Compartment-like Structure That Exerts the Structural and Physiological Functions of the Viral Replication Compartment
by
Tania Sultana, Chunfeng Zheng, Jenna Jones, Nina Zamani, Maria Pilar Toledo, Garret M. Morton, Yue J. Wang and Timothy L. Megraw
Viruses 2026, 18(8), 834; https://doi.org/10.3390/v18080834 - 29 Jul 2026
Abstract
Zika virus (ZIKV) is a mosquito-transmitted orthoflavivirus that caused an epidemic in 2015–2016 in the Americas and raised serious global health concerns due to its association with congenital brain anomalies when infections occur during pregnancy. Various viruses can form compartments within the cell
[...] Read more.
Zika virus (ZIKV) is a mosquito-transmitted orthoflavivirus that caused an epidemic in 2015–2016 in the Americas and raised serious global health concerns due to its association with congenital brain anomalies when infections occur during pregnancy. Various viruses can form compartments within the cell to facilitate viral replication and assembly, referred to as viroplasms, replication organelles, or virus factories depending on the type of virus. ZIKV assembles virus particles in virus-generated compartments adjacent to the nucleus, referred to here as a replication compartment (RC), which is formed by remodeling the host cell endoplasmic reticulum (ER). How the viral proteins control RC assembly remains unknown. Here we show that the ZIKV non-structural protein 3 (NS3), a dual-function protease and RNA helicase, is sufficient to drive the assembly of a replication compartment-like structure (RCLS) in human cells. While sufficient to generate the RCLS, NS3 is less efficient in several aspects compared to ZIKV-induced RC assembly. Nonetheless, the RCLS is similar to the ZIKV RC in its assembly at the nuclear periphery, its recruitment of ER, association with the Golgi and centrosome, and the arrangement of microtubules at its surface. Moreover, NS3 expression results in activation of the unfolded protein response (UPR), but attenuates expression of the downstream transcription factor CHOP, mirroring the manipulation of the different aspects of the UPR by ZIKV infection. We further show that the helicase domain and not the protease domain is required for optimal RCLS formation and organelle recruitment, yet each domain affects different control over the UPR. Overall, these findings advance our understanding of the mechanism of RC assembly by ZIKV, its involvement in hijacking the UPR, and the central role of NS3 in the process.
Full article
(This article belongs to the Special Issue Functional Structures in RNA Viruses)
►▼
Show Figures

Graphical abstract
Open AccessArticle
A Panel of VHH Antibodies Against Sabin Type 1 Poliovirus D-Antigen Reveals Strain-Specific and Cross-Serotype Reactivity
by
Maya Ermakova, Sergey Ivanov, Olga Shmeleva, Nadezhda Borisenko, Anna Zyrina, Stepan Chumakov, Igor Levin, Regina Yakupova, Marina Merkulova, Anna Shishova, Yury Ivin, Anastasia Piniaeva, Alexandra Siniugina and Aydar Ishmukhametov
Viruses 2026, 18(8), 833; https://doi.org/10.3390/v18080833 - 29 Jul 2026
Abstract
Vaccination remains the primary strategy for poliomyelitis prevention. The D-antigen of poliovirus is a critical component of inactivated polio vaccines, as it induces the production of neutralizing antibodies and provides protective immunity. Therefore, the development of quantitative immunoassays for monitoring D-antigen content during
[...] Read more.
Vaccination remains the primary strategy for poliomyelitis prevention. The D-antigen of poliovirus is a critical component of inactivated polio vaccines, as it induces the production of neutralizing antibodies and provides protective immunity. Therefore, the development of quantitative immunoassays for monitoring D-antigen content during vaccine production is an important task. In this study, we generated recombinant camelid single-domain antibodies (VHHs) specific for the D-antigen of Sabin poliovirus type 1 and evaluated their antigen specificity. The obtained VHH antibodies demonstrated strong binding to the native D-antigen of Sabin type 1 poliovirus. Furthermore, the use of clone S1-C7 as a capture antibody in combination with Sabin type 1-specific polyclonal antibodies for detection revealed differential recognition of the vaccine-derived Sabin type 1 and homologous wild-type Mahoney strains. Notably, such discrimination was not observed when polyclonal antibodies were used alone, indicating that incorporation of VHH S1-C7 into the assay enhances strain-specific antigen recognition. In a neutralization assay, clone S1-C7 exhibited in vitro neutralizing activity against Sabin type 1 poliovirus. One clone, S1-D9, demonstrated cross-reactivity with all three poliovirus serotypes, suggesting recognition of a conserved epitope in the capsid and potential utility as a universal detection antibody. The generated VHH antibodies represent promising analytical tools for poliovirus antigen characterization. Together with S1-C7, they enable the discrimination of both D- and C-antigen forms as well as vaccine-derived and wild-type strains.
Full article
(This article belongs to the Special Issue An Update on Enterovirus Research, 2nd Edition)
►▼
Show Figures

Figure 1
Open AccessArticle
SARS-CoV-2 Surveillance in Free-Ranging Wildlife in New England and Virginia, United States, 2022–2025
by
Idrissa Nonmon Sanogo, Wendy B. Puryear, Alexa F. Simulynas, Elena Cox, Maureen Murray, Zain Khalil, Harm van Bakel, Martin J. R. Feehan, Zak Mertz, Priya Patel, Jennifer Riley, Blaine Hymel and Jonathan A. Runstadler
Viruses 2026, 18(8), 832; https://doi.org/10.3390/v18080832 - 29 Jul 2026
Abstract
Since its emergence in 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected a wide range of animal species, including wildlife. Although SARS-CoV-2 infection has been widely reported in wildlife, particularly in white-tailed deer (WTD; Odocoileus virginianus) across the United States,
[...] Read more.
Since its emergence in 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected a wide range of animal species, including wildlife. Although SARS-CoV-2 infection has been widely reported in wildlife, particularly in white-tailed deer (WTD; Odocoileus virginianus) across the United States, data on viral circulation in New England wildlife remain limited. Here, we investigated active SARS-CoV-2 infection and serological evidence of previous exposure in free-ranging wildlife from New England and Virginia. We examined samples from 1646 animals representing 29 wildlife species, collected through wildlife rehabilitation centers, clinics, and hunter harvests in New England and Virginia between 2022 and 2025. SARS-CoV-2 RNA was detected in three WTD from Massachusetts and Vermont. Phylogeographic analysis showed that the Vermont WTD SARS-CoV-2 sequences were closely related to contemporaneous human SARS-CoV-2 sequences from the same region, consistent with a possible human-to-deer spillover event. Serological screening by ELISA detected SARS-CoV-2 reactive samples in nine individuals from three species, including Eastern cottontail (Sylvilagus floridanus), Eastern coyote (Canis latrans), and raccoon (Procyon lotor), providing putative evidence of prior SARS-CoV-2 exposure. However, neutralizing antibodies against the SARS-CoV-2 Omicron variant were detected in only a single Eastern cottontail. Overall, these findings indicate sporadic SARS-CoV-2 detection and limited serological evidence of prior exposure among wildlife sampled in New England and Virginia, and highlight the importance of continued surveillance to detect spillover events, monitor viral evolution, and assess the potential risks associated with wildlife reservoirs.
Full article
(This article belongs to the Special Issue Molecular Epidemiology of SARS-CoV-2, 4th Edition)
►▼
Show Figures

Figure 1
Open AccessArticle
Hematological Profile and Outcomes in Newly Diagnosed Patients with HIV: A 12-Month Single-Centre Cohort Study
by
Monica-Daniela Padurariu-Covit, Magdalena Miulescu, Pompiliu-Mircea Bogdan, Iulian Stoleriu, Ancuta Elena Tupu and Manuela Arbune
Viruses 2026, 18(8), 831; https://doi.org/10.3390/v18080831 - 28 Jul 2026
Abstract
Hematological abnormalities are frequent in newly diagnosed people living with HIV (PLWH), yet their prognostic significance remains incompletely defined. We conducted a retrospective single-center cohort study including newly diagnosed PLWH evaluated between 2018 and 2024 and analyzed hematological, immunological, virological, and inflammatory parameters
[...] Read more.
Hematological abnormalities are frequent in newly diagnosed people living with HIV (PLWH), yet their prognostic significance remains incompletely defined. We conducted a retrospective single-center cohort study including newly diagnosed PLWH evaluated between 2018 and 2024 and analyzed hematological, immunological, virological, and inflammatory parameters at diagnosis and after 12 months of antiretroviral therapy (ART). Most patients presented with advanced HIV disease and severe immunosuppression. Anemia was the most frequent hematological abnormality and was associated with lower CD4 counts, higher HIV viral load, and reduced survival. Elevated C-reactive protein (CRP) levels and the presence of multiple cytopenias were also associated with poorer outcomes. Notably, patients with two or more cytopenias had significantly reduced overall survival, suggesting that multilineage hematopoietic impairment may reflect advanced systemic disease. Significant hematological and immunological recovery was observed after 12 months of ART. These findings indicate that hematological abnormalities in newly diagnosed HIV infection reflect the interplay between immune dysfunction, systemic inflammation, and impaired hematopoiesis. Multiple cytopenias may serve as readily accessible prognostic biomarkers and could improve early risk stratification in PLWH.
Full article
(This article belongs to the Special Issue HIV Infection, Latency, Pathogenesis and Associated Comorbidities, Including Cancer and Inflammation in the Context of Drugs of Abuse and ART)
►▼
Show Figures

Figure 1
Open AccessArticle
The Innate Antiviral Factors APOBEC3G and APOBEC3H Interact with the Nucleocapsids of Human Coronaviruses in an RNA-Dependent Manner
by
Jordi Exposito Trivino, Alexandra Decloux, Margaux Renier, Théo Massart, Justine Petit, Maxence Collard, Kévin Willemart, Aurélien Sellier, Rodrigue Tesse, Samuel Kindylides, Jean-Claude Twizere, Charles Nicaise, Lionel Tafforeau and Nicolas A. Gillet
Viruses 2026, 18(8), 830; https://doi.org/10.3390/v18080830 - 28 Jul 2026
Abstract
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) evolution has been marked by the rapid accumulation of mutations, among which cytosine-to-uracil (C-to-U) transitions represent a major proportion of observed genomic changes. These mutations have been proposed to result from the activity of host APOBEC3
[...] Read more.
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) evolution has been marked by the rapid accumulation of mutations, among which cytosine-to-uracil (C-to-U) transitions represent a major proportion of observed genomic changes. These mutations have been proposed to result from the activity of host APOBEC3 cytidine deaminases, innate immune enzymes capable of editing viral RNA. However, the molecular mechanisms underlying APOBEC3 involvement in SARS-CoV-2 biology remain poorly understood. Here, we systematically investigated physical interactions between APOBEC family members and the SARS-CoV-2 proteins using a Gaussia princeps protein complementation assay. Screening of APOBEC family proteins against the viral proteome identified specific interactions between APOBEC3G (A3G) and APOBEC3H (A3H) with the viral nucleocapsid (N) protein. These interactions were validated by co-immunoprecipitation and were found to be conserved across nucleocapsid proteins from all seven human coronaviruses, suggesting conserved structural determinants. Mechanistic analyses revealed that the RNA-binding and oligomerization capacities of A3G and A3H are key for their interaction with the SARS-CoV-2 nucleocapsid. Mapping experiments further showed that the C-terminal domain of N constitutes the minimal interacting region, with stronger binding observed in larger constructs encompassing adjacent regions, indicating cooperative stabilization. Further work will be needed to determine whether A3G and/or A3H can restrict viral replication and whether their interaction with the nucleocapsid allows them to access and mutate the viral genome.
Full article
(This article belongs to the Special Issue Viruses 2026—New Horizons in Virology)
►▼
Show Figures

Figure 1
Open AccessBrief Report
The FIB-4 Is a Marker of Monocyte/Macrophage Activation Independently from Severe Hepatic Disease in People Living with HIV on Stable and Successful Treatment
by
Matteo Vassallo, Roxane Fabre, Sara Ferrando, David Chirio, Leslie Ameil, Maeva Godemert, Alissa Naqvi, Eric Cua, Edouard Tuaillon, Amandine Pisoni, Christian Pradier, Michel Carles and Jacques Durant
Viruses 2026, 18(8), 829; https://doi.org/10.3390/v18080829 - 28 Jul 2026
Abstract
Objectives: Despite successful antiretroviral treatment (ART), people living with HIV (PWH) continue experiencing chronic immune activation and comorbidities. We analysed whether the Fibrosis 4 index (FIB-4) is associated with monocyte–macrophage activation in PWH with non-severe hepatic disease. Materials and Methods: We performed a
[...] Read more.
Objectives: Despite successful antiretroviral treatment (ART), people living with HIV (PWH) continue experiencing chronic immune activation and comorbidities. We analysed whether the Fibrosis 4 index (FIB-4) is associated with monocyte–macrophage activation in PWH with non-severe hepatic disease. Materials and Methods: We performed a cross-sectional analysis about factors associated with monocyte–macrophage activation among PWH either on triple or dual ART. Background measurements, comorbid conditions and FIB-4 values were correlated with plasmatic markers of monocyte–macrophage activation (sCD163 and sCD14) using univariate and linear regression analysis. Results: We included 366 subjects (age 60.5, 75% male, years of HIV infection 24.5, mean FIB-4 1.52, 8% with FIB-4 > 2.67, Body Mass Index 24.5). In univariate analysis, FIB-4 was associated with older age, years of HIV infection, ART duration, lower CD4/CD8 ratio at inclusion, lower nadir CD4, higher sCD14 and sCD163 values, living alone, dyslipidaemia, high blood pressure and diabetes (p < 0.05 for all). In multivariate analysis FIB-4 ≥ 1.3 was associated with sCD163 values ≥ 782 ng/mL [AdjOR 1.85, 95% CI [1.05; 3.33] p = 0.035], independently from CD4 count, ART duration, living alone, hepatitis C, high blood pressure and alcohol. Conclusions: The FIB-4 is a simple tool reliable for monocyte–macrophage activation in PWH, able to define subjects with higher risks of complications.
Full article
(This article belongs to the Section Human Virology and Viral Diseases)
►▼
Show Figures

Graphical abstract
Open AccessArticle
Oropouche Virus: Comparative Study of Two Strains Reveals Distinct Innate Immunity Modulation
by
Letizia Rizzo, Giulia Alessandri, Gianni Gori Savellini, Sara Caldrer, Concetta Castilletti and Maria Grazia Cusi
Viruses 2026, 18(8), 828; https://doi.org/10.3390/v18080828 - 28 Jul 2026
Abstract
Oropouche virus (OROV), an Orthobunyavirus of the Peribunyaviridae family, is usually transmitted to humans by biting midges, while, to date, cases of human-to-human transmission have not been reported. Although OROV’s clinical manifestation is usually characterized by mild symptoms, cases of Central Nervous System
[...] Read more.
Oropouche virus (OROV), an Orthobunyavirus of the Peribunyaviridae family, is usually transmitted to humans by biting midges, while, to date, cases of human-to-human transmission have not been reported. Although OROV’s clinical manifestation is usually characterized by mild symptoms, cases of Central Nervous System (CNS) infections have been reported. The non-structural protein NSs of many bunyaviruses and phleboviruses acts as a major virulence factor. Previous studies have demonstrated that OROV NSs also behaves as a suppressor of the host IFN-α/β responses. Furthermore, OROV NSs protein promotes cellular RPB1 proteasomal degradation to suppress RNA synthesis. In the present work, we perform a comparative study on two OROV strains (BeAn19991 and IRCCS-SCDC_1/2024) to further characterize the molecular mechanisms by which OROV NSs inhibits IFN-β expression. Our results demonstrate that the NSs protein mediates a reduction in IFN-β promoter activation, hindering RIG-I and IRF-3, therefore acting on multiple steps of the IFN-β signaling pathway. However, this suppression seems to reside in the blockage of RPB1 rather than a direct effect on those mediators. Moreover, we investigated the behavior of the two virus strains in a human glioblastoma cell line derived from brain (DBTRG.05MG cells) and fibroblasts (MRC-5 cells), observing different replication kinetics, degradation activity towards RPB1, and strength/timing of IFN-β modulation.
Full article
(This article belongs to the Special Issue Virology in Italy 2025—9th National Congress of the Italian Society for Virology)
►▼
Show Figures

Figure 1
Open AccessArticle
Single-Tube Reverse Transcription–Loop-Mediated Isothermal Amplification Assay for Rapid Detection of Red-Spotted Grouper Nervous Necrosis Virus in Fish Species
by
Mangottil Ayyappan Pradeep, Cherammpillil Sukumaran Subin, Gokhlesh Kumar, Sulumane Ramachandra Krupesha Sharma, Nadiyath Karayi Sanil, Thaliyil Veetil Arun Kumar, Nikathil Raveendranathan Dhanutha, Thevanattil Sairanksha Azhar Shahansha and Koyadan Kizhakkedath Vijayan
Viruses 2026, 18(8), 827; https://doi.org/10.3390/v18080827 - 27 Jul 2026
Abstract
Betanodavirus is a causative agent of viral nervous necrosis (VNN) and a major threat to marine and brackish-water aquaculture globally. This virus causes epizootic outbreaks with particularly high morbidity and mortality in larval and juvenile stages and causes significant economic losses in aquaculture.
[...] Read more.
Betanodavirus is a causative agent of viral nervous necrosis (VNN) and a major threat to marine and brackish-water aquaculture globally. This virus causes epizootic outbreaks with particularly high morbidity and mortality in larval and juvenile stages and causes significant economic losses in aquaculture. Here, we developed a rapid and highly sensitive single-tube Reverse Transcription–Loop-Mediated Isothermal Amplification (RT-LAMP) assay for the detection of red-spotted grouper nervous necrosis virus (RGNNV) genotype infection in fish tissue samples. Six primers targeting eight conserved regions of the RNA2 coat protein gene of RGNNV were designed with conservation regions across RGNNV genotypes. RT-LAMP assay was completed within 60 min at 65 °C using a single-tube format that combined reverse transcription and isothermal amplification, and results were directly visualized by the addition of SYBR Green I dye, producing a colour change from orange (negative) to green (positive), observable with the naked eye or under UV illumination. The developed RT-LAMP assay was able to detect five copies of RGNNV from infected samples, which was 20-fold more sensitive than conventional reverse transcription-PCR. The assay demonstrated diagnostic sensitivity and specificity in two fish hosts (Asian seabass and cobia) and showed no cross reactivity with other fish viruses such as tilapia lake virus and cyprinid herpesvirus-2. The developed assay is simple, cost-effective, specific, and enables rapid detection of RGNNV in fish tissues. This single-tube RT-LAMP assay can be applied to screening broodstock facilities, fingerlings, aquaculture farms, quarantine facilities, and juveniles before stocking in ponds or cages, helping prevent disease outbreaks and the transmission of RGNNV in aquaculture systems.
Full article
(This article belongs to the Special Issue Viral Diseases of Aquatic Animals: Crustaceans, Mollusks, Fish, Sea Turtles, and Marine Mammals)
►▼
Show Figures

Figure 1
Journal Menu
► ▼ Journal Menu-
- Viruses Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserHighly Accessed Articles
Latest Books
E-Mail Alert
News
Topics
Topic in
Animals, Encyclopedia, Pathogens, TropicalMed, Veterinary Sciences, Viruses, Zoonotic Diseases
Emerging and Resurging Viruses: Zoonotic Threats in a Changing World
Topic Editors: Levon Abrahamyan, Francesco VairoDeadline: 31 March 2027
Topic in
Biomedicines, Cancers, IJMS, Vaccines, Viruses, JMP
Advances in HPV-Driven Head and Neck Cancer: Pathogenesis, Treatment, and Prevention
Topic Editors: Shilpi Gupta, Bhudev Chandra Das, Prabhat KumarDeadline: 20 April 2027
Topic in
Antibiotics, Diseases, Vaccines, Viruses, Epidemiologia
HIV Prevention and Treatment: A Guide to Health and Safety
Topic Editors: Olanrewaju Oladimeji, Martha ChadyiwaDeadline: 31 December 2027
Conferences
7–9 April 2027
Meet Us Virtually at the 4th International Electronic Conference on Microbiology, 7–9 April 2027

11–14 June 2027
International Veterinary Science Conference 2027: Integrating Veterinary Science and One Health for Global Wellbeing

Special Issues
Special Issue in
Viruses
Immune Modulation by Human Cytomegalovirus: 2nd Edition
Guest Editor: Davide AbateDeadline: 1 August 2026
Special Issue in
Viruses
Control and Contributions of Transposable Elements: Implications for Development and Disease
Guest Editors: Suzanne B. Sandmeyer, Henry L. LevinDeadline: 14 August 2026
Special Issue in
Viruses
Infectious Disease Epidemiology: Current Updates and Perspectives
Guest Editors: Agata Skrzat-Klapaczynska, Justyna Dominika KowalskaDeadline: 15 August 2026
Special Issue in
Viruses
Rift Valley Fever Virus: New Insights into a One Health Archetype
Guest Editors: Rebekah C. Kading, Juliette Lewis, Brian H. BirdDeadline: 16 August 2026
Topical Collections
Topical Collection in
Viruses
Efficacy and Safety of Antiviral Therapy
Collection Editors: Giordano Madeddu, Andrea De Vito, Agnese Colpani



